UAB "Apeironpharma" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statement report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2022 |
---|
502,073 |
129,068 |
51,886 |
44,103 |
11,338 |
37.09 |
8.78 |
128,557 |
71,475 |
89,293 |
110,739 |
2023 |
---|
537,218 |
134,305 |
78,849 |
67,022 |
16,756 |
36.50 |
12.48 |
214,399 |
366,388 |
444,776 |
151,159 |
2024 |
---|
501,278 |
125,320 |
74,743 |
63,532 |
15,883 |
37.44 |
12.67 |
277,931 |
305,251 |
533,777 |
84,694 |
Register and
explore Okredo dataRegister and
explore Okredo data2024
Turnover (€)
501,278 €-7 % *
Sales per employee (€)
125,320 €-7 % *
Profit before tax (€)
74,743 €-5 % *
Net Profit (€)
63,532 €-5 % *
Profit per employee (€)
15,883 €-5 % *
Total profitability (%)
37.44 %2.58 % *
Net profitability (%)
12.67 %1.52 % *
Equity (€)
277,931 €30 % *
Amounts Payable And Liabilities (€)
305,251 €-17 % *
Non-current Assets (€)
533,777 €20 % *
CurrentAssets (€)
84,694 €-44 % *